GGrantIndex
Sort

48,018 grants matching immunotherapy

In Vitro Approach To Problems of Clinical Allergy

$580,541
Johns Hopkins University · R01 · FY2005 · AI

Spatiotemporal regulation of collective cell behaviors in Drosophila

$580,495
Denise J. Montell · University Of California Santa Barbara · R01 · FY2022 · GM

Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts

$580,454
Stephen C. Dreskin · University Of Colorado Denver · R01 · FY2025 · AI

Functional roles of human pulmonary DC's in the lung draining lymph nodes

$580,448
Claudia V Jakubzick · Dartmouth College · R01 · FY2019 · HL

Project 1: Co-stimulation and Regulation of Anti-viral Immunity

$580,442
Arlene H Sharpe · Harvard Medical School · P01 · FY2021 · AI

ChAT, AChE, and Cholinergic Neurons in Aging and AD

$580,311
Steven G Younkin · Mayo Clinic Jacksonville · R01 · FY2008 · AG

Molecular Immunology and Tumor Biology

$580,275
David Michael Langenau · Massachusetts General Hospital · T32 · FY2023 · CA

Immune response to Pneumocystis in simian model of AIDS

$580,262
Karen A Norris · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · HL

Clinical treatment of advanced Merkel cell carcinoma

$580,211
Isaac Brownell · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2025 · AR

TCR signaling and cell cycle regulation in tumor-specific CD8 T cell dysfunction

$580,177
Mary Philip · Vanderbilt University Medical Center · R37 · FY2022 · CA

Defining mechanisms to promote antitumor immunity by modulating one-carbon metabolism

$580,136
Arlene H Sharpe · Harvard Medical School · R01 · FY2023 · CA

Cell type-directed Tim-3 targeting in melanoma

$580,109
Steven Russell Barthel · Brigham And Women'S Hospital · R01 · FY2025 · CA

Innate lymphoid cell regulation of the host-microbiota interactions in cancer

$580,093
Gregory F Sonnenberg · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA

Enhancing efficacy of virus-specific T cell therapy following hematopoietic stem cell transplantation by CD52 knockout

$579,879
Michael Daniel Keller · Children'S Research Institute · R33 · FY2025 · HL

Epigenetic and immunologic aspects of neuroendocrine cancers

$579,811
Nitin Roper · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Analyses of human T regulatory cells

$579,726
Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Specific Adoptive Immunotherapy of Leukemia

$579,708
Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2011 · CA

Immunometabolic Programs Controlled by ER Stress in Cancer

$579,622
Juan R Cubillos-Ruiz · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA

Subcellular enzyme-instructed self-assembly for molecular anticancer nanomedicines

$579,612
Bing Xu · Brandeis University · R01 · FY2024 · CA

Project 1: Transgenic TCR-mediated tumor therapy

$579,552
Philip D Greenberg · University Of Washington · P01 · FY2023 · CA

Epigenetic Programming of T Cells for Enhanced Cellular Immunotherapy

$579,428
Charles A Gersbach · Duke University · R01 · FY2025 · CA

Targeted therapy of B cell malignances with CAR-T cells of defined composition

$579,424
Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA

Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment

$579,420
Laurie McLouth · University Of Kentucky · R01 · FY2024 · CA

Aged T-cell-derived cytokines impact meningeal lymphatics and contribute to AD

$579,380
Jonathan Kipnis · Washington University · R01 · FY2023 · AG

Molecular epidemiology of non-Hodgkin lymphoma prognosis and prevention

$579,375
Sophia S. Wang · Beckman Research Institute/City Of Hope · R01 · FY2015 · CA